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Abstract
The amino acid L-arginine inhibits bacterial coaggregation, is involved in cell-cell signaling,
and alters bacterial metabolism in a broad range of species present in the human oral cavi-
ty. Given the range of effects of L-arginine on bacteria, we hypothesized that L-arginine
might alter multi-species oral biofilm development and cause developed multi-species bio-
films to disassemble. Because of these potential biofilm-destabilizing effects, we also hy-
pothesized that L-arginine might enhance the efficacy of antimicrobials that normally cannot
rapidly penetrate biofilms. A static microplate biofilm system and a controlled-flow microflui-
dic system were used to develop multi-species oral biofilms derived from pooled unfiltered
cell-containing saliva (CCS) in pooled filter-sterilized cell-free saliva (CFS) at 37oC. The ad-
dition of pH neutral L-arginine monohydrochloride (LAHCl) to CFS was found to exert negli-
gible antimicrobial effects but significantly altered biofilm architecture in a concentration-
dependent manner. Under controlled flow, the biovolume of biofilms (μm3/μm2) developed
in saliva containing 100-500 mM LAHCl were up to two orders of magnitude less than when
developed without LAHCI. Culture-independent community analysis demonstrated that 500
mM LAHCl substantially altered biofilm species composition: the proportion of Streptococ-
cus and Veillonella species increased and the proportion of Gram-negative bacteria such as
Neisseria and Aggregatibacter species was reduced. Adding LAHCl to pre-formed biofilms
also reduced biovolume, presumably by altering cell-cell interactions and causing cell de-
tachment. Furthermore, supplementing 0.01% cetylpyridinium chloride (CPC), an antimicro-
bial commonly used for the treatment of dental plaque, with 500 mM LAHCl resulted in
greater penetration of CPC into the biofilms and significantly greater killing compared to a
non-supplemented 0.01% CPC solution. Collectively, this work demonstrates that LAHCl
moderates multi-species oral biofilm development and community composition and en-
hances the activity of CPC. The incorporation of LAHCl into oral healthcare products may
be useful for enhanced biofilm control.
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Introduction
Dental plaque biofilms are surface-associated microbial communities that are bathed in flow-
ing saliva and typically contain tens to hundreds of bacterial species [1]. Oral biofilm architec-
ture, species composition, and spatial arrangement of the contained species impact growth-
rates and can enhance tolerance to adverse environmental conditions [2,3,4]. Depending upon
the location (supragingival versus subgingival), the biomass (number of bacteria), the species
composition (types and relative abundance), and spatial arrangement of the constituent species
(in three dimensions), dental plaque biofilms can cause caries or periodontal disease [2,5,6].
Dental plaque biofilm communities are extremely recalcitrant to external chemical and physi-
cal perturbations. For example, they are up to 1,000 times less susceptible to antimicrobials
compared to their planktonic counterparts, and are typically resistant to abrasive treatments
[7,8]. Difficulties in treating oral biofilm communities, especially those causing dental caries
and periodontal disease, imparts a considerable health burden in the US: approximately 500
million visits to dental offices and an estimated cost of $108 billion per annum to treat or pre-
vent oral disease [9].
In recent years, there have been concerns with the possible overuse of antibiotics and biocides
to maintain or improve oral health [10,11,12]. Adaptation of bacteria to these antimicrobials
and the spread of genetic resistances via the horizontal exchange of antimicrobial resistance
genes could arise. Consequently, various novel alternatives to antimicrobials have been investi-
gated for the control of dental plaque biofilms [8,13]. Notable examples include inhibitors of
cell-cell signaling [14], enzyme-based technologies [15,16], and the use of oral probiotic organ-
isms [17]. In addition, attention has focused upon the use of amino acids such as L-arginine that
have been indicated to help prevent the development of cariogenic dental plaque biofilms
[18,19,20,21]. Research into the mechanism of action of L-arginine has primarily centered on
the ability of oral streptococci to catabolize L-arginine and consequently generate a local pH rise
that counteracts the deleterious effects of acid on teeth [22,23]. Evidence also suggests that,
while micromolar concentrations of L-arginine metabolically stabilize bacteria within coaggre-
gates [24] and can mediate cell-cell signaling in dental plaque biofilms [24,25], millimolar con-
centrations can disaggregate bacterial coaggregates [26,27] and can influence the adhesion of
Streptococcus mutans to tooth surfaces [21]. With a clear potential for a multifaceted role for L-
arginine in biofilm metabolism and development, we hypothesized that L-arginine might desta-
bilize oral multi-species biofilm communities. Specifically, destabilization would be expressed as
changes in biofilm biomass, biofilm architecture and biofilm species community composition as
a result of cell loss, altered cellular metabolism, and other effects caused directly or indirectly by
L-arginine. Furthermore, because biofilms are inherently tolerant of antimicrobials, in-part due
to slowed growth and restriction of access/penetration of antimicrobials, destabilized communi-
ties also might be more susceptible to antimicrobial treatments.
When studying oral biofilms, there has been considerable attention focused on in vitro labo-
ratory model biofilm systems to develop biofilms of single-species or defined multi-species com-
munity composition that use artificial media [28,29,30,31]. While providing potentially useful
baseline data for studies of biofilm developmental processes or the impact of candidate anti-bio-
film compounds, single-species models ignore inter-species interactions that are a cornerstone
for oral biofilm development [2]. Furthermore, the use of artificial media can generate biofilm
communities that contain cells which are metabolically and phenotypically dissimilar to their
normal state in flowing saliva [32,33]. Following recent technological advances, we have devel-
oped a flowing saliva microfluidic-based system that uses a Bioflux platform to evaluate the ef-
fect of anti-biofilm and antimicrobial compounds on multi-species biofilms grown under
environmentally relevant conditions [34]. Specifically, the system does not require the use of
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defined species or artificial media at any stage of model preparation or use. Unlike the larger-
scale systems such as constant depth film fermentors (CDFFs) and flowcells, ours only requires
milliliters of filtered, pooled human saliva per experiment, as a media source and as little as 100
microliter inoculums of pooled human saliva. Furthermore, the Bioflux system is compatible
with confocal laser scanning microscopy and technologies that facilitate the detection/quantifi-
cation of microorganisms using culture-independent techniques. As such, the system offers an
attractive in vitromodel to evaluate the impact of L-arginine on multi-species biofilms that con-
tain species often documented to exist in in vivo oral biofilms and grown under flowing condi-
tions similar to those observed in the human oral cavity (saliva, pH, temperature, shear/flow).
This study aimed to employ two different model biofilm systems to examine the effects of
L-arginine on multi-species oral biofilms: a technically simple static system and the controlled-
flow Bioflux microfluidic system. Since L-arginine is inherently basic, and can exert confound-
ing pH effects on biofilms, we focused on using L-arginine monohydrochloride (LAHCl)
which displays a more neutral pH in saliva than L-arginine free base and has been demonstrat-
ed to be physiologically compatible for oral administration [18,35]. The static model biofilm
system provided a high-throughput approach to optimize a bolus delivery of LAHCl and exam-
ine any gross anti-biofilm and antimicrobial effects while the controlled-flow system (the Bio-
flux model) allowed us to examine the long-term and short-term effects of LAHCl by
providing continual flow and replenishment of nutrients which more closely mimicked the
oral cavity. Both model systems allowed for the evaluation of the effects of LAHCl on oral
multi-species biofilms developed from an inoculum of pooled cell-containing saliva with filter
sterilized 25% pooled saliva used as the nutrient medium. Furthermore, both systems utilized
confocal laser scanning microscopy to evaluate biofilm architecture and viability. Biofilms
grown within the Bioflux system were subject to community composition analysis by 454 pyro-
sequencing. Here, we show that high millimolar concentrations of LAHCl alter biofilm three-
dimensional architecture and biovolume in static saliva-based (microplate) and controlled-
flow saliva-based (Bioflux) model systems, and we demonstrate that LAHCl can significantly
alter multi-species biofilm community composition under natural flowing saliva conditions. In
addition, we show that LAHCl can enhance the antimicrobial efficacy of cetylpyridinium chlo-
ride (CPC), a cationic antimicrobial that is commonly used in oral healthcare products but is
subject to retarded biofilm penetration [34,36]. Collectively, findings from this work provide a
framework for future fundamental and applied biofilm-control studies based on the use of
LAHCl.
Materials and Methods
Nutrient and Inoculum Collection and Preparation
A saliva collection protocol, that did not collect the identifiers of individuals and facilitated the
generation of pooled human saliva, was reviewed by the University of Michigan Health Sci-
ences and Behavioral Sciences Institutional Review Board and given a “not regulated status”
(Study eResearch ID: HUM00042954). As described by Nance and colleagues [34], saliva was
collected from 6 individuals and pooled. The pooled saliva was used as either a cell-containing
saliva (CCS) inoculum or as a cell-free saliva (CFS) nutrient source. CCS was prepared by mix-
ing pooled saliva with glycerol (25% final glycerol concentration) before storing at -80°C. CFS
was prepared by adding 2.5 mM of the reducing agent dithiothreitol (DTT) to pooled saliva fol-
lowed by centrifugation at 17,000 x g for 30 min. The supernatant was mixed with sterile dis-
tilled water to make 25% saliva before filter-sterilizing through a 0.22 μm pore-size PES filter
(Nalge Nunc International, Rochester, NY) and storage at -80°C.
L-Arginine Destabilizes Oral Multi-Species Biofilms
PLOS ONE | DOI:10.1371/journal.pone.0121835 May 6, 2015 3 / 18
Static Microplate System
Static oral multi-species biofilms were developed in 24-well glass-bottom Sensoplate microplates
(Greiner Bio-One, Monroe, NC) using CFS as the sole nutrient source and CCS as the inoculum.
When required, L-arginine HCl (LAHCl) was added to CFS at final concentrations between
50 μM–500 mM (10-fold increments). 1.5 mL of CFS (negative control) and supplemented CFS
of different LAHCl concentrations were added to each well. Wells were inoculated with 15 μL of
CCS. After incubation at 37°C for 22 h, wells were treated with BacLight LIVE/DEAD viability
stain (3.34 μM Syto 9 and 20 μM propidium iodide) (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. After 30 min, the stained biofilms were washed with 1 mL of phos-
phate-buffered saline (PBS; pH: 7.4) three times, and examined microscopically.
Flow-Based Microfluidic System
Using the approach of Nance and coworkers [34], 24-channel Bioflux plates (Fluxion, San Fran-
cisco, CA) were first treated with CFS to improve cell adhesion by flowing 100 μL of CFS across
the inner-channel surfaces at 1 dyn/cm2 for 2 min and subsequently allowed to stand for 20 min.
To inoculate the system, 100 μL of CCS were added to each outlet-well and flowed toward the
inlet-well at 1 dyn/cm2 for 6 s. The plate was incubated at 37°C for 40 min to facilitate cell adhe-
sion. Next, 900 μL of CFS (supplemented with or without LAHCl, described below) were added
to each inlet-well and flowed toward the outlet well at 0.2 dyn/cm2 at 37°C for 20 h.
Effect of Sustained Exposure of Different Concentrations of L-Arginine
HCl (LAHCl) on Oral Biofilm Architecture and Viability
LAHCl was added to CFS to final concentrations between 500 μM and 500 mM. The supple-
mented or non-supplemented CFS was used as the medium source for the inoculated Bioflux
flowing biofilm system and was added 40 min after initial inoculation with CCS. After 20 h in-
cubation (37°C), the pH of the spent supplemented and non-supplemented CFS was checked
and the developed biofilms were washed in PBS (pH 7.4; 20 min, 0.2 dyn/cm2) and stained
using BacLight LIVE/DEAD viability stain according to the manufacturer’s instructions (Invi-
trogen, Carlsbad, CA) for 45 min at room temperature. Excess stain was removed by flowing
100 μL of PBS (pH 7.4) at 0.2 dyn/cm2 over biofilms for 20 min at room temperature.
Culture-Independent Analysis of Oral Biofilm Community Composition
Biofilm cells were harvested and the samples were analyzed using bacterial tag encoded FLX
amplicon pyrosequencing (bTEFAP), using the primers 939F (5’-TTGACGGGGGCCCGCAC-
3’) and 1492R (5’-TACCTTGTTACGACTT-3’) by a method similar to that described by
Nance and coworkers [34]. Briefly, cells from developed biofilms were harvested by pulsing
sterile distilled water through the microfluidic channels at 20.0 dyn/cm2 (flow rate 745 mL/h,
corresponding to a shear of 800 s-1) in both the forward and the reverse directions, in order to
create shear stress to remove biofilm cells. This washing procedure was repeated until 90% or
more (based upon microscopic inspection of surface-coverage) of the bound biofilm cells had
been removed.
DNA was extracted from the harvested biofilm cells using a Qiagen DNA preparation system
(Qiagen, Valencia, CA), according to the manufacturer’s instructions. Single step PCR was per-
formed to generate barcoded amplicons with linkers. The concentration and size of DNA frag-
ments were determined using DNA chips within a Bio-Rad Experion Automated Electrophoresis
Station (Bio-Rad Laboratories, Hercules, CA) and a TBS-380 Fluorometer (Promega Corpora-
tion, Madison, WI). The 454 sequencing run was performed on a 70 × 75 GS PicoTiterPlate
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using a Genome Sequencer FLX System (Roche, Nutley, NJ). Sequence quality control was per-
formed as described previously [37]. To determine the predicted identity of bacteria, remaining
sequences were de-noised and de-replicated. OTU clustering was performed using uClust
(http://www.drive5.com) and then queried using BLASTn against a custom highly curated data-
base of 16S ribosomal RNA sequences derived from the National Center Biotechnology Informa-
tion (http://www.ncbi.nlm.nih.gov/). BLASTn outputs were compiled and data reduction
analysis was carried-out using the approach of Callaway et al. [38].
Evaluation of the Ability of LAHCl to Augment the Activity of
Antimicrobials
Using a 24-channel Bioflux plate and following 20 h growth in CFS (described above), wells
were aspirated and biofilms were washed with PBS (pH 7.4). Biofilms were then exposed to an-
timicrobial/LAHCl mixtures for 60 s by flowing 100 μL of the mixtures over the biofilms at 2
dynes/cm2. Treatments included 0.05% cetylpyridinium chloride (CPC), 0.01% CPC, 0.05%
CPC plus 500 mM LAHCl, 0.01% CPC plus 500 mM LAHCl, 500 mM LAHCl, or sterile dis-
tilled water (negative control). Wells were immediately aspirated before adding PBS (pH 7.4)
to the inlet wells and flowed towards the outlet wells at 0.2 dynes/cm2 for 20 minutes to elimi-
nate the residual treatment solutions. Biofilms were stained using the BacLight LIVE/DEAD
stain, as described above.
Microscopy, Computational Biofilm Rendering, and Image Analysis
Biofilms were examined using a Leica (Leica, Exon, PA) SPE confocal laser scanning micro-
scope (CLSM) equipped with a 10X 0.4 NA HC PL APO infinity corrected objective lens (for
static saliva biofilm microplate assays) or a 40X 1.25 NA HCX PL APO infinity corrected ob-
jective lens (for flowing saliva biofilm Bioflux assays). A 488 nm laser (15% power) was used to
excite the LIVE/DEAD stained biofilms. For unbiased image acquisition and analyses, gain and
offset settings were kept constant and the emission capture gates (Syto 9: EM: 510–540 nm and
propidium iodide: EM: 620–650 nm) were set to be the same for every experiment. Imaris soft-
ware (Bitplane, Zurich, Switzerland) was used to render and visualize biofilms. COMSTAT
[39] and IMAGEJ [40] were used to assess parameters such as biofilm biovolume (the total vol-
ume occupied by fluorescent cells per unit of substratum area), average biofilm thickness (the
mean biofilm thickness in a field of view), (dimensionless) biofilm roughness (a measure of
how much the thickness of the biofilm varies), and viability (percentage of fluorescent green
staining of biofilm by Syto 9). For image analysis using COMSTAT, all image stacks underwent
manual thresholding checks that were based upon visual inspection of 3D biofilm renderings
in IMARIS and histograms calculated in IMAGEJ.
Statistical analyses
Two-tailed Student's T-tests that accounted for unequal variances were performed for all IMA-
GEJ and COMSTAT derived data. Values of p<0.05 were considered significant.
Results
Exposure to Millimolar Concentrations of L-Arginine HCl Alter Biofilm
Architecture under Static Conditions
Microcosm biofilms were developed in a static glass bottom microplate biofilm system that was
inoculated with CCS and used CFS with increasing concentrations of LAHCl (50 μM–500
mM) as the growth medium. After 22 h growth, the architecture of the biofilms was observed
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to be substantially altered in a LAHCl concentration-dependent manner. Large biofilm towers
that projected from surfaces into the overlying liquid were reduced at higher LAHCl concen-
trations in favor of smaller biofilm microcolonies with very occasional large biofilm masses
(Fig 1A–1F). With the exception of 50 mM and 500 mM LAHCl, LIVE/DEAD staining of the
biofilms grown at different LAHCl concentrations revealed that the supplementation of saliva
with LAHCl consistently resulted in no statistically significant change in viability (Fig 1). Bio-
films developed in 50 mM and 500 mM LAHCl displayed a modest but significant decrease in
viability (Fig 1 associated table). However, visual inspection of the biofilms developed in 50
mM and 500 mM LAHCl suggested that the red signal was likely due to non-responsive/dead
cells that are typically seen in multi-species biofilms but their proportion was increased, poten-
tially due to the change in biofilm architecture and biomass (Fig 1E and 1F versus 1A–1D).
Across all biofilm communities that were grown in CFS with or without LAHCl, red cells were
always occasionally observed in small discrete patches that generally consisted of<10 cells of
varying size and shape within or on the exterior regions of biofilms (Fig 1A–1F).
Sustained Millimolar Concentrations of L-Arginine HCl Reduce Biofilms
under Flowing Conditions
In the human oral cavity, saliva constantly flows over supragingival biofilms allowing for the
mass-transfer of nutrients into the biofilm and the sloughing/de-adhesion/dispersion of bio-
film cells to other areas. In addition, the flow of saliva maintains relatively stable concentrations
of nutrients, in contrast to batch culture systems where nutrients such as arginine may be con-
sumed by bacteria. To simulate the oral cavity more closely, a Bioflux microfluidic system was
used to develop biofilms from inocula of CCS in flowing CFS supplemented with different con-
centrations of LAHCl. Microscopic inspection of LIVE/DEAD stained biofilms that were de-
veloped across the range of LAHCl concentrations revealed the presence of numerous
morphologically distinct cell-types including cocci, rods, and fusiforms (S1 Fig). CLSM-derived
renderings of the biofilms showed an inverse relationship between architectural complexity
and exposure to increasing LAHCl. Specifically, as the LAHCl concentration increased, the
ratio of small microcolonies to larger biofilm masses increased. By 100 mM LAHCl, no large
biofilm masses were observed (CLSM renderings within Fig 2).
Quantitative image analysis using COMSTAT confirmed visual observations, and there
were significant decreases in the biovolumes of biofilms developed in LAHCl concentrations of
100 mM (P<0.001, Fig 2). CFS supplemented with100 mM LAHCl displayed a biovolume
that was decreased by approximately 10–100 fold over the non-supplemented CFS control. A
similar trend was also observed for average biofilm thickness. Roughness data supported the
biovolume and thickness data (as well as the rendered images) suggesting that, when grown in
higher millimolar LAHCl concentrations, the biofilms were much more sparse than the non-
supplemented control. While an overall trend of a one-to-two order decrease in magnitude in
biofilm biovolume was observed in the high millimolar range, at the low millimolar range,
there was a concentration that supported a modest increase in biofilm biovolume. Biofilms de-
veloped within flowing CFS supplemented with an intermediate concentration (with respect to
studied range) of 5 mM LAHCl displayed a two-fold increase in biovolume and thickness. The
increase was accompanied by a large standard deviation and the biofilms contained the occa-
sional large seemingly loosely-surface-attached microcolonies that flexed and moved in a gelat-
inous-like fashion as the microscope stage moved. There were even fewer occasional large
loosely-attached microcolonies when biofilms were developed CFS supplemented with 50 mM
LAHCl and above this concentration large biofilm masses were not observed.
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Fig 1. Differences in architecture of oral biofilms grown a static biofilm system containing different
concentrations of L-arginine monohydrochloride (LAHCl). Images show representative 3D renderings of
22 h-old oral biofilms grown from a cell-containing saliva (CCS) inoculum in the static biofilm system
containing cell free saliva (CFS) supplemented with different concentrations of LAHCl. Green signal (Syto 9)
indicates viable cells and red signal (propidium iodide) indicates damaged/dead cells. Upper renderings (A1–
F1) are of the x–y plane. Middle renderings (A2–F2) are of the x–z plane. Lower renderings (A3–F3) represent
an angled view (x–y–z). Bars represent 50 μm. The associated table shows changes in percentage of cell
viability with means presented in bold and standard deviations shown in parentheses (each derived from at
least 27 images from nine biological replicates). *P<0.05; **P<0.01: significant differences from the
CFS control.
doi:10.1371/journal.pone.0121835.g001
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Using IMAGEJ software, the percent viability of biofilms was derived from LIVE/DEAD
stained biofilm cells. Viability measurements suggested that the destabilizing effects by LAHCl
caused a small but significant decrease in viability at5 mM LAHCl (except 100 mM LAHCl).
Because of the seemingly indiscriminate location of dead/damaged biofilm cells and a broad-
range of cell-types seen to be inactive, this was deemed to be possibly due to the random re-
moval of viable cells from biofilm regions.
Sustained Millimolar L-Arginine HCl Concentrations Alter Species
Composition under Flowing Conditions
Considering the striking difference in biofilm architecture that developed as a result of growth
in flowing CFS supplemented with 500 mM LAHCl, we opted to use bTEFAP to compare com-
munity composition of the architecturally distinct biofilms to those formed in flowing non-
Fig 2. Effects of flowing saliva supplemented with different LAHCl concentrations on the development of oral biofilms for 20 h in the Bioflux
system. The graph shows differences in biofilm biovolume and representative CLSM 3D renderings are included to highlight differences in biofilm
architecture. Light blue colored star symbols embedded in the graph indicate a significant increase in average biofilm biovolume over CFS control and orange
colored star symbols embedded in the graph indicate a significant decrease in average biofilm biovolume over CFS control. For the rendered biofilms within
the embedded images, green colored cells indicate viable cells and red colored cells indicate damaged/dead cells. Bars represent 20 μm. The associated
table shows, in addition to the biovolumes highlighted in the graph, changes in average biofilm thickness, average biofilm roughness, and cell viability. For
data presented in the associated table, means are shown in bold and standard deviations are shown in parentheses (each derived from at least 18 images
from six biological replicates). *P<0.05; **P<0.01; ***P<0.001: significant differences from the CFS control.
doi:10.1371/journal.pone.0121835.g002
L-Arginine Destabilizes Oral Multi-Species Biofilms
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supplemented CFS. Differences were observed in the total number of different genera, and the
abundance of phyla/genera between biofilms developed in flowing non-supplemented CFS and
500 mM LAHCl supplemented CFS (Fig 3A, 3B, and 3C). Rarefaction analysis showed that
even though biofilms grown in 500 mM LAHCl were reduced in biovolume (Fig 2), the diversi-
ty was almost two-fold greater than biofilms cultured in non-supplemented CFS (Fig 3A). At
the phylum level, significant differences in the percent abundance of members of the Proteo-
bacteria, Bacteroidetes, Fusobacteria, and Firmicutes were detected. The abundance of Proteo-
bacteria in biofilms grown in flowing CFS supplemented with 500 mM LAHCl was less than
half that in those grown in flowing non-supplemented CFS (Fig 3B). This decrease in abun-
dance of Proteobacteria was mirrored by increase in abundances of Bacteroidetes, Fusobacteria,
and Firmicutes within biofilms developed in flowing CFS supplemented with 500 mM LAHCl.
The genera whose differences contributed to the decrease in abundance in the Proteobacteria
phylum included Neisseria spp. (from an average of 49.76% to an average of 8.62%) and Aggre-
gatibacter spp. (from an average of 8.16% to an average of 0.38%) (Fig 3C, S1 Table). The in-
crease in abundances of the phyla Bacteroidetes, Fusobacteria, and Firmicutes was largely due
to increases in Prevotella spp. (from an average 0.03% to an average 4.91%) Fusobacterium spp.
(from an average 0.05% to an average 5.88%), Veillonella spp. (from an average 0.22% to an av-
erage 17.95%), and Streptococcus spp. (from an average 13.06% to an average 23.02%). From a
total biomass perspective, it should be noted that changes in abundances of phyla/genera with-
in the biofilms developed in flowing CFS supplemented with 500 mM LAHCl are also subject
to the change in total bioburden: the absolute amount of biofilm cells/biofilm biomass, as in-
ferred by CLSM and COMSTAT. Specifically, the development of biofilms in CFS supple-
mented with 500 mM LAHCl reduced biofilm biovolume by approximately 100-fold, when
compared to non-supplemented saliva (highlighted in Fig 3C).
Transient Exposure to L-Arginine HCl Reduces Biofilms and Enhances
the Antimicrobial Activity of CPC
Given that LAHCl destabilizes biofilm architecture, we tested whether high concentrations of
LAHCl could enhance antimicrobial penetration and killing. Biofilms were developed from
CCS in flowing non-LAHCl supplemented CFS for 20 h and then exposed for 60 s to 0.05% or
0.01% CPC either with or without 500 mM LAHCl (Fig 4). Three-dimensional rendering and
image analysis demonstrated that treating oral biofilms with 500 mM LAHCl for 60 s reduced
biofilm biovolume and thickness (P<0.05) as well as viability (P<0.01), presumably by causing
de-adhesion of biofilm/coaggregated cells (Fig 4A versus 4F and associated table). Mixing 500
mM LAHCl with 0.05% CPC did not show enhanced killing/damage of biofilm cells, as com-
pared with the non-LAHCl-augmented 0.05% CPC treatment (Fig 4B versus 4C and associated
table), presumably because CPC was in excess. In contrast, mixing 500 mM LAHCl with a de-
creased amount of CPC (0.01%) resulted in significantly more (P<0.01) killing compared to
the 0.01% CPC treatment (Fig 4D versus 4E and associated table). Three-dimensional compu-
tational rendering clearly supported image analysis data (Fig 4) and two data sets that were par-
ticularly contrasting was the 0.01% CPC treatment versus the 0.01% CPC treatment that was
supplemented with 500 mM LAHCl. Rendering of the 0.01% CPC treated biofilm showed that
killing was restricted to the upper parts of the biofilms (Fig 4D) while 0.01% CPC supple-
mented with 500 mM LAHCl resulted in almost complete penetration and killing (Fig 4E).
Discussion
Using a static multi-species model biofilm system and a controlled-flow microfluidic multi-
species model biofilm system, we demonstrated that L-arginine monohydrochloride (LAHCl)
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Fig 3. Sustained exposure to LAHCl alters biofilm community composition.Oral biofilms developed in
the Bioflux system containing flowing CFS supplemented with 500 mM LAHCl display an altered biofilm
community composition compared to those developed in non-supplemented CFS. Data derived from
bacterial tag-encoded FLX amplicon pyrosequencing of oral biofilms grown for 20 h in three Bioflux
microfluidic channels exposed to flowing CFS (control) and three Bioflux microfluidic channels exposed to
flowing CFS supplemented with 500 mM LAHCl. (A) Comparison of OTU (97% identity) richness derived from
rarefaction curves for biofilms developed in non-supplemented CFS (black square symbols) and biofilms
developed in CFS supplemented with 500 mM LAHCl (grey square symbols). (B) Comparison of differences
in abundance of phyla. Black bars represent data derived from the analysis of biofilms developed in flowing
non-supplemented CFS while the grey bars represent data derived from the analysis of biofilms developed in
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does not kill or damage biofilm bacteria but instead, appears to destabilize the biofilm in a con-
centration-dependent manner. Destabilization was inferred from the observed changes to ar-
chitecture and biovolume occupied as well as relative proportions of the contained species. It is
possible that LAHCl inhibited bacterial growth to some extent. However, by visualizing outlet
wells from the Bioflux, there was evidence of growth even in the presence of 500 mM LAHCl
(S2 Fig). Furthermore, the supplementation of 500 mM LAHCI with a cationic antimicrobial
(CPC), which is common to many commercial mouthwashes, resulted in enhanced biofilm
penetration and killing of cells. To our knowledge, this is the first demonstration that LAHCl
can have multifaceted effects leading to changes in the community composition, architecture,
and antimicrobial susceptibility of oral multi-species biofilms.
Many approaches to control oral biofilms rely upon the use of chemical agents to exert di-
rect bactericidal or bacteriostatic effects. These approaches have garnered concern as they will
conceivably promote the development of antimicrobial resistance [10]. The use of LAHCl to
instead destabilize multi-species oral biofilms, resulting in the reduction of biofilm bioburden,
represents a potentially desirable alternative to antimicrobial treatments because the dispersed
bacteria will be either swallowed or expelled during cleaning regimens. It is not clear if biofilm
bacteria could become resistant to the effects of L-arginine (in this case in the form of the salt
LAHCl) because the mechanism(s) of action of LAHCl has yet to be determined. We hypothe-
size that LAHCl has multifaceted effects on the stability of oral biofilms (Fig 5). These include a
decrease in viscosity of extracellular polymeric substances produced by bacteria [41], an alter-
ation in cellular metabolism that results in biofilm dispersion and reduced antibiotic tolerance
[42], an imbalance in cell-cell metabolic communication [43], changes in local pH due to the
break-down of L-arginine [44], alteration in cell-cell signaling [25], and disruption of coaggre-
gation that conceivably results in cell-cell rearrangement in biofilms [45]. When considering
the possible anti-coaggregation effects, it should be noted that it is not always entirely clear
from the previous published studies of the effect of L-arginine on coaggregation whether the
pH neutral salt (LAHCl) was used or if the more alkaline L-arginine free base was used
[46,47,48,49]. Thus, pH might have had a role in inhibiting coaggregation in those previous
studies. However, we have performed our own studies using both forms of L-arginine and both
have been shown to inhibit coaggregation (S3 Fig). It is also possible that high concentrations
of LAHCl may exert an osmotic pressure that causes loss of membrane integrity resulting in
cell damage and/or death [50]. However, as inferred by LIVE/DEAD staining, cell death in the
static or flowing biofilm systems was minimal and certainly much less than those levels docu-
mented for saliva-grown oral biofilms treated with antimicrobials [34] (Figs 1, 2, and S2 Fig).
Collectively, the data suggest that the treatment of oral biofilms with LAHCl results in very lim-
ited cell-death, possibly due to the development of unfavorable biofilm conditions (e.g. changes
in oxygen tension due to architectural changes to the biofilms); however, LAHCl does not exert
direct antimicrobial effects. It is likely that the relative contribution of each of these LAHCl-in-
duced effects depends upon not only the concentration of LAHCl but also duration of exposure
(Fig 5). For example, short-term transient exposures that reduce biofilm biomass would likely
be due to rapid de-adhesion events caused by inhibition of coaggregation (as well as inhibition
of non-specific cell-cell adhesion). Long-term sustained exposure would likely have a multitude
of effects including inhibition of coaggregation, altered metabolism by cells (caused directly by
CFS supplemented with 500 mM LAHCl. (C) Comparisons of differences in abundances of genera whereby
abundances are normalized to biofilm biovolume (calculated from data presented in Fig 2). Note color coding
(from left to right in the key) follows the order frommost abundant in the CFS control. Far right color-coded bar
is a magnified view of the community composition of the biofilm developed in CFS supplemented with 500
mM LAHCl. Supporting data is available in S1 Table.
doi:10.1371/journal.pone.0121835.g003
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Fig 4. LAHCl affects preformed biofilms and enhances antimicrobial effectiveness. Demonstration that a 60 s exposure of oral multi-species biofilms
developed in flowing cell free saliva (CFS) to solutions supplemented with LAHCl reduces biofilm biovolume and enhances antimicrobial efficacy of
cetylpyridinium chloride (CPC). Representative biofilm renderings show 20 h oral biofilms developed from pooled CCS in flowing CFS in the Bioflux
microfluidic system and subsequently exposed for 60 s to 0.05% or 0.01%CPC with or without 500 mM LAHCl. Green signal (Syto 9) shows viable cells, red
signal (propidium iodide) shows damaged/dead cells. Upper images (A1–F1) are of the x–y plane. Middle images (A2–F2) are of the x–z plane. Lower images
(A3–F3) are an angled view of each plane (x–y–z). Bars represent 20 μm. Associated table shows changes in cell viability, biofilm biovolume, thickness, and
roughness. For data presented in the associated table, means are presented in bold and standard deviations are shown in parentheses (each derived from at
least 9 images from three biological replicates). *P<0.05, **P<0.01: significant differences from the H2O control; ▪P<0.05, ▪▪P<0.01: significant differences
from 0.05% CPC treatment; †P<0.05, ††P<0.01: significant differences from 0.01% CPC treatment.
doi:10.1371/journal.pone.0121835.g004
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available L-arginine and indirectly by changes in the position of interacting species in the
multi-species biofilm), and altered cell-cell signaling. An interesting study to follow-up the
work presented here would be to examine how repeated short-term transient exposures affect
the community over the long-term (Fig 5). This repeated dosing effect is especially relevant
when one considers that this is the type of repetitive exposure that one would envisage for the
treatment of natural biofilm communities within the human oral cavity.
Cationic antimicrobials are known to be less effective against slow-growing bacteria [51] and
subject to reaction diffusion limitation, which limits penetration to deeper lying cells [4]. Con-
sidering that our data shows that LAHCl enhances the antimicrobial activity of CPC (Fig 4), it is
likely that LAHCl enhances the metabolic activity of cells, making themmore susceptible to
CPC, and also allows for greater and more rapid biofilm penetration of CPC because of inhibi-
tion of coaggregation. It is also possible that LAHCl alters the sticky extracellular polysaccharide
framework that aids in biofilm support/retention, which would also enhance CPC penetration
[41]. However, more work needs to be performed on less complex (single- or dual-species) bio-
film populations to fully elucidate how LAHCl enhances killing.
The most effective LAHCl concentrations for destabilizing biofilms were between 50 and
500 mM; lower concentrations displayed reduced effects. Formulations containing similar high
millimolar concentrations of L-arginine have been commercialized for use in oral rinses and
oral pastes to treat dentin hypersensitivity [52]. The mechanism of action of these L-arginine
containing rinses and pastes centers upon the loading and occlusion of dentin tubules as well
as the coating of tooth surfaces [53]. As such, a residual high concentration of L-arginine could
remain in the oral cavity after initial exposure—resulting in sustained retention-times promot-
ing long-term oral biofilm destabilization. Recently, clinical work has begun to look at the po-
tential of L-arginine to modulate oral biofilm communities, by stimulating the production of
alkali in the form of ammonia by bacterial arginine dihydrolase pathway enzymes [18,23]. This
is hypothesized to contribute to changes in community composition in carious multi-species
biofilms to select against cariogenic S.mutans. In this context, it would be interesting to exam-
ine the effect of L-arginine in the form of LAHCl on in vitromodel multi-species biofilms
Fig 5. A model showing the proposed biofilm destabilizing effects of short-term exposure (transient; minutes) and longer-term exposure
(sustained; hours) to highmillimolar (100mM) LAHCl concentrations in flowing saliva. The model shows the effect of LAHCl on a well-developed
multi-species biofilm (with respect to architecture and species composition) although similar destabilizing effects would occur on multi-species biofilms of
younger or older developmental age. Cell shapes and sizes are not to scale. Postulated effects are based on data presented in this manuscript and on
previous observations of the effects of L-arginine on bacterial cells and cell-cell interactions, as discussed in the body of the text.
doi:10.1371/journal.pone.0121835.g005
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containing S.mutans as well as revisiting the effect of LAHCl on in vivo biofilms as part of a
clinical study.
An advantage to using the Bioflux microfluidic biofilm system, over other model biofilm
systems, is that it allows us to replicate conditions found in the human oral cavity to generate
multi-species biofilm communities that display a species composition similar to dental plaque
[54]. Indeed, given the dominance of Neisseria species, the high levels of Streptococcus and
Granulicatella species, and the numerous but less abundant characteristic anaerobic species
(including members of the candidate division TM7 at low abundances), it is clear that the bio-
films grown in the Bioflux microfluidic biofilm system contained species with abundances that
are similar to that detected in human immature oral supragingival plaque [55,56,57]. Supple-
menting the saliva with 500 mM LAHCl not only altered biofilm architecture and reduced bio-
film biovolume, but also changed the biofilm community from one that contained a large
proportion of Neisseria spp. followed by Granulicatella and Streptococcus spp. to one that was
dominated by Streptococcus spp. followed by Veillonella, Neisseria spp., and Fusobacterium
spp. In particular, Streptococcus spp. are well-known to catabolize arginine [44] and it is possi-
ble that members of this genera benefitted directly from using L-arginine (in the form of
LAHCl) as a nutrient. Further, Veillonella spp. often co-localize with streptococci since they
use lactate, which is an end-product of streptococcal carbohydrate metabolism [58]. Thus, the
increase in abundance of Veillonella spp. is potentially a consequence of the larger lactate-
producing population of streptococci. The abundance of Fusobacterium spp. also increased in
LAHCl treated biofilms (again, with respect to proportion of entire community). While an ob-
ligate anaerobe and typically only detected in more mature biofilm communities, the increase
in abundance of Fusobacterium spp. may partly be accounted for by the ability of this organism
to coaggregate with many oral species. Some coaggregation interactions may be inhibited by
the presence of LAHCl [59,60] but other coaggregation interactions may not [61]. Thus, the
multigeneric coaggregation-mediated bridging ability of Fusobacterium spp. [5,62] may give it
an ability to reside in LAHCl containing environments when other species are removed. In
context with a very recent clinical study, L-arginine was also shown to affect the composition
of dental plaque in caries-free and caries-active subjects, as measured by microarray [18]. How-
ever, it is difficult to compare the data with our observations due to the very different in vivo
and in vitro techniques employed and different research focus. Nevertheless, it is interesting to
note that in that clinical study the proportions of Neisseria, Fusobacterium and Veillonella were
also altered by L-arginine.
Given the destabilizing effects of high millimolar concentrations of LAHCl, as well as the in-
creasing demand to develop more efficacious oral healthcare technologies, the prospect of
using L-arginine salts such as LAHCl to improve oral health needs to be rigorously assessed. As
well as fundamental mechanistic studies, clinical investigations exploring the use of L-arginine
salts in antimicrobial formulations would also be potentially fruitful. Indeed, it is also possible
that the treatment of biofilms with LAHCl may extend beyond oral applications and may be of
use in destabilizing biofilms in other environments such as in wounds, catheters, and other
medically or environmentally relevant situations.
Supporting Information
S1 Fig. Magnified and digitally enhanced three dimensional reconstructions showing ex-
amples of cell-types and cell arrangements within oral biofilms developed in the Bioflux
microfluidic system. (A) A mixture of cell-types in coaggregated microcolonies in a biofilm
developed in CFS. (B) A fusiform-like cell with coaggregated cocci that is partially exposed and
projecting from microcolonies in a biofilm developed in CFS. (C) Long chains of streptococci
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in loose masses in a biofilm developed in CFS supplemented with 100 mM LAHCl. (D). A
microcolony of densely-packed cocci in a biofilm developed in CFS supplemented with 500
mM LAHCl. Bars represent 5 μm.
(TIF)
S2 Fig. Presence or absence of biofilm through the Bioflux microfluidic system following
20 h growth at 37°C in CFS or CFS containing 500 mM LAHCl. System was flooded with
LIVE/DEAD stain to highlight which cells were alive (green) or damaged/dead (red). (A) When
grown in CFS that was not supplemented with LAHCl, no substantial biofilm was observed in
the inlet well (very occasional fluorescent material was detected) and sizeable biofilms were ob-
served in the channels and outlet wells. (B) When grown in CFS supplemented with 500 mM
LAHCl, no substantial biofilm was observed in the inlet well (very occasional fluorescent materi-
al was detected), no substantial biofilm was observed in the channels (mostly small microcolo-
nies of cells), but large biofilm masses were seen in the outlet well. Note there was no visible
reduction in viability in the presence of LAHCl in the outlet well. Blue circles represent area of
evaluation for biofilm. Bars represent 30 μm.
(TIF)
S3 Fig. Supplementing coaggregation buffer with either LAHCl or L-arginine (free base)
inhibits coaggregation between three species of oral bacteria. Cells of the oral species Strepto-
coccus gordoniiDL1 (SgDL1), Streptococcus oralis 34 (So34), and Actinomyces oris T14V
(AoT14V) were grown in batch culture and suspended in coaggregation buffer according to the
method of Cisar and colleagues [63]. Suspensions of equal cell density (optical density of 1.5 at
600nm; A-C) were then mixed in equal volumes (400μl of each species) in coaggregation buffer
(D-F) or coaggregation buffer supplemented with either LAHCl (G-I) or L-arginine (free base)
(J-L). Visual scores ranging from 0 (no coaggregation) through 4+ (maximum coaggregation)
were assigned using the criteria of Cisar and colleagues [63]. Scale bar represents 5 mm.
(TIF)
S1 Table. Species composition of biofilms developed from pooled CCS inoculums in the
Bioflux biofilm system containing flowing CFS supplemented with or without 500 mM
LAHCl. Average percentage abundance of each species based on bacterial tag-encoded FLX
amplicon pyrosequencing of oral biofilms grown for 20 h in three Bioflux microfluidic chan-
nels exposed to flowing CFS (control) and in three Bioflux microfluidic channels exposed to
flowing CFS supplemented with 500 mM LAHCl. Unspeciated sequences are assigned to re-
spective genera and highlighted in bold. Values are rounded to two decimal places. It should be
noted that relative abundances are subject to primer bias and are therefore approximate.
(PDF)
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